DailyStocks Stock Article Search

https://www.rttnews.com/story.aspx?Id=3526211 Apr 02, 2025 - AngioDynamics, Inc. (ANGO) Wednesday reported net loss of $4.41 million or $0.11 per share for the third quarter, significantly lower than $187.74 million or $4.67 per share loss in the same quarter a year ago, primarily due to goodwill impairment charges of $159.48 million in the prior-year quarter. The medical technology company's shares were more than 10 percent up in pre-market. 0

https://www.sandiegouniontribune.com/2025/04/01/ouch-san-diego-gas-prices-up-21-cents-in-little-more-than-a-week/ Apr 01, 2025 - Fuel analysts blame tight supplies due to refinery outages and the switch to more expensive summer blended gasoline 0

https://seekingalpha.com/article/4771929-rotation-time-3-dividend-stocks-yielding-up-to-10-percent-i-expect-to-beat-the-market?source=feed Apr 01, 2025 - 0

https://www.ocregister.com/2025/03/31/dodgers-beat-braves-run-season-opening-winning-streak-to-6-games/ Mar 31, 2025 - Making his first start since Aug. 11, Tyler Glasnow gives up just one hit in five scoreless innings and Teoscar and Kiké Hernandez hit home runs in a 6-1 series-opening win. 0

https://seekingalpha.com/article/4772074-eis-etf-attractive-valuation-cautionary-technical-indicators?source=feed_tag_etf_portfolio_strategy Mar 31, 2025 - 0

https://www.rttnews.com/3525246/australia-rate-decision-on-tap-for-tuesday.aspx?type=alleco Mar 31, 2025 - The Reserve Bank of Australia will wrap up its monetary policy meeting and then announce its decision on interest rates, highlighting a busy day for Asia-Pacific economic activity. The RBA is widely expected to keep its benchmark lending rate steady at 4.10 percent. 0

https://seekingalpha.com/news/4426938-nls-pharmaceutics-announces-up-to-3m-and-25m-equity-facility-agreement-to-support-merger-with-kadimastem?source=feed_sector_healthcare Mar 31, 2025 - 0

https://seekingalpha.com/article/4771704-stop-plunging-toilets-for-your-tenants-get-paid-7-5-percent-yields-instead?source=feed Mar 31, 2025 - 0

https://www.rttnews.com/story.aspx?Id=3525443 Mar 31, 2025 - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced Monday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation or BTD for darovasertib monotherapy in neoadjuvant uveal melanoma. 0

https://seekingalpha.com/article/4771259-coreweave-rent-is-going-up-get-out-now?source=feed_tag_ipo_analysis Mar 28, 2025 - 0